Softbank Vision Fund L.p. - Net Worth and Insider Trading
Softbank Vision Fund L.p. Net Worth
The estimated net worth of Softbank Vision Fund L.p. is at least $2.4 Billion dollars as of 2024-11-13. Softbank Vision Fund L.p. is the 10% Owner of Myovant Sciences Ltd and owns about 40,765,599 shares of Myovant Sciences Ltd (MYOV) stock worth over $1.1 Billion. Softbank Vision Fund L.p. is the 10% Owner of Roivant Sciences Ltd and owns about 83,031,667 shares of Roivant Sciences Ltd (ROIV) stock worth over $966 Million. Softbank Vision Fund L.p. is also the 10% Owner of Urovant Sciences Ltd and owns about 22,860,013 shares of Urovant Sciences Ltd (UROV) stock worth over $371 Million. Details can be seen in Softbank Vision Fund L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Softbank Vision Fund L.p. has not made any transactions after 2023-03-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Softbank Vision Fund L.p.
Softbank Vision Fund L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Softbank Vision Fund L.p. owns 7 companies in total, including Arbutus Biopharma Corp (ABUS) , Sio Gene Therapies Inc (SIOX) , and Myovant Sciences Ltd (MYOV) among others .
Click here to see the complete history of Softbank Vision Fund L.p.’s form 4 insider trades.
Insider Ownership Summary of Softbank Vision Fund L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | 2017-09-06 | 10 percent owner |
| SIOX | Sio Gene Therapies Inc | 2018-12-18 | 10 percent owner |
| MYOV | Myovant Sciences Ltd | 2019-06-04 | 10 percent owner |
 | | 2019-07-10 | other: Former 10% Owner |
| | 2023-03-20 | 10 percent owner |
| | 2022-12-08 | 10 percent owner |
| | 2022-12-08 | 10 percent owner |
Softbank Vision Fund L.p. Latest Holdings Summary
Softbank Vision Fund L.p. currently owns a total of 3 stocks. Among these stocks, Softbank Vision Fund L.p. owns 40,765,599 shares of Myovant Sciences Ltd (MYOV) as of June 4, 2019, with a value of $1.1 Billion and a weighting of 45.12%. Softbank Vision Fund L.p. owns 83,031,667 shares of Roivant Sciences Ltd (ROIV) as of March 20, 2023, with a value of $966 Million and a weighting of 39.65%. Softbank Vision Fund L.p. also owns 22,860,013 shares of Urovant Sciences Ltd (UROV) as of June 19, 2019, with a value of $371 Million and a weighting of 15.23%.
Latest Holdings of Softbank Vision Fund L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MYOV | Myovant Sciences Ltd | 2019-06-04 | 40,765,599 | 26.98 | 1,099,855,861 |
| ROIV | Roivant Sciences Ltd | 2023-03-20 | 83,031,667 | 11.64 | 966,488,604 |
| UROV | Urovant Sciences Ltd | 2019-06-19 | 22,860,013 | 16.24 | 371,246,611 |
Holding Weightings of Softbank Vision Fund L.p.
Softbank Vision Fund L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Softbank Vision Fund L.p. has made a total of 0 transactions in Myovant Sciences Ltd (MYOV) over the past 5 years. The most-recent trade in Myovant Sciences Ltd is the acquisition of 2,424,242 shares on June 4, 2019, which cost Softbank Vision Fund L.p. around $20 Million.
According to the SEC Form 4 filings, Softbank Vision Fund L.p. has made a total of 2 transactions in Roivant Sciences Ltd (ROIV) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Roivant Sciences Ltd is the sale of 12,000,000 shares on March 20, 2023, which brought Softbank Vision Fund L.p. around $96 Million.
According to the SEC Form 4 filings, Softbank Vision Fund L.p. has made a total of 0 transactions in Urovant Sciences Ltd (UROV) over the past 5 years. The most-recent trade in Urovant Sciences Ltd is the acquisition of 18,204 shares on June 19, 2019, which cost Softbank Vision Fund L.p. around $151,457.
Insider Trading History of Softbank Vision Fund L.p.
- 1
Softbank Vision Fund L.p. Trading Performance
GuruFocus tracks the stock performance after each of Softbank Vision Fund L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Softbank Vision Fund L.p. is 5.03%. GuruFocus also compares Softbank Vision Fund L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Softbank Vision Fund L.p. within 3 months outperforms 7 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Softbank Vision Fund L.p.'s insider trading performs compared to the benchmark.
Performance of Softbank Vision Fund L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.14 | | | | | |
| Relative Return to S&P 500(%) | -2.61 | | | | | |
Softbank Vision Fund L.p. Ownership Network
Ownership Network List of Softbank Vision Fund L.p.
Ownership Network Relation of Softbank Vision Fund L.p.
Softbank Vision Fund L.p. Owned Company Details
What does Arbutus Biopharma Corp do?
Who are the key executives at Arbutus Biopharma Corp?
Softbank Vision Fund L.p. is the 10 percent owner of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and Chief Scientific Officer Michael J. Sofia .
Arbutus Biopharma Corp (ABUS) Insider Trades Summary
Over the past 18 months, Softbank Vision Fund L.p. made no insider transaction in Arbutus Biopharma Corp (ABUS). Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 10,164 shares made by Michael J. Mcelhaugh , a net sale of 9,982 shares made by Michael J. Sofia , and a net sale of 9,593 shares made by David C Hastings .
In summary, during the past 3 months, insiders sold 8,846 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 8,846 shares. During the past 18 months, 42,943 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,943 shares.
Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arbutus Biopharma Corp Insider Transactions
Softbank Vision Fund L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Softbank Vision Fund L.p.. You might contact Softbank Vision Fund L.p. via mailing address: Aztec Group House, 11-15 Seaton Place, St Helier Y9 Je4 0qh.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
